Ann: MDR December 2017 Quarterly Report & Appendix 4C, page-7

Last time I checked The App is buggy and underdeveloped but lacking real competition. Might have changed..

Not on board for this second push upward but if they can hold onto / grow their userbase their value will grow exponentially regardless of immediate revenues. Its all about the users here and the value of that user base to other business's.

I think of it as social media platform(now used mainly to gather user habits and sell products) but for pharma's and doctors. If big data really picks up an existing large userbase will be invaluable.

Has the potential to go big if they can build on momentum.

Best of luck to all investors!